Risk Factors for Cardiovascular Disease in Type 1 Diabetes

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group·2016·Diabetes

Cited by (209)

Items 101–200 of 209

  1. Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study
    W.H. Wilson Tang, Paula McGee, John M. Lachin, D. Li, Byron J. Hoogwerf, Stanley L. Hazen, D.M. Nathan, Bernard Zinman, O. Crofford, SAUL M. GENUTH et al. · 2018 · Journal of the American Heart Association
  2. Metabolic health and vascular complications in type 1 diabetes
    Sandhya Bhattarai, Ian F. Godsland, Shivani Misra, Desmond G. Johnston, Nick S. Oliver · 2019 · Journal of Diabetes and its Complications
  3. Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study
    Ionut Bebu, Sareh Keshavarzi, Xiaoyu Gao, Barbara H. Braffett, Angelo J. Canty, William H. Herman, Trevor John Orchard, Samuel E. Dagogo-Jack, David M. Nathan, John M. Lachin et al. · 2021 · Diabetes Care
  4. Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
    Kristine Bech Holte, Mona Svanteson, Kristian Folkvord Hanssen, Kari Anne Sveen, Ingebjørg Seljeflot, Svein Solheim, David R. Sell, Vincent M. Monnier, Tore Julsrud Berg · 2020 · PLoS ONE
  5. The Theory of Hyperlipidemic Memory of Type 1 Diabetes
    Benjamin Udoka Nwosu · 2022 · Frontiers in Endocrinology
  6. Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1
    Emmanuel Cosson, Marie Auzanneau, Gloria Aguayo, Wölfram Karges, Jean‐Pierre Riveline, Petra Augstein, Laura Sablone, Peter Michael Jehle, Guy Fagherazzi, Reinhard Walter Holl et al. · 2024 · Cardiovascular Diabetology
  7. Evaluation of the Steno Type 1 Risk Engine in predicting cardiovascular events in an ethnic mixed population of type 1 diabetes mellitus and its association with chronic microangiopathy complications
    Isabella Cristina Paliares, Patricia Medici Dualib, Laísa Stephane Noronha Torres, Priscila Maria Teixeira Aroucha, Bianca de Almeida-Pititto, João Roberto de Sá, Sérgio Atala Dib · 2024 · Cardiovascular Diabetology
  8. Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis
    Alex Mesa, Josep Franch‐Nadal, Elena Navas, Dı́dac Mauricio · 2025 · Cardiovascular Diabetology
  9. Glycolytic activity in human immune cells: inter-individual variation and functional implications during health and diabetes
    Frank Vrieling, Xanthe A.M.H. van Dierendonck, Martin Jaeger, Anna W.M. Janssen, Anneke Hijmans, Mihai Gheorghe Netea, Cees J. Tack, Rinke Stienstra · 2022 · Immunometabolism
  10. Impact of remnant cholesterol and triglycerides on diabetes foot and disease in type 1 diabetes: A propensity score-matched case-control study
    Fernando Sebastián‐Valles, Alberto Santiago-Redondo, Elena García-Artacho, Miguel Antonio Sampedro-Nuñez, Víctor Navas-Moreno, José Alfonso Arranz Martín, Mónica Marazuela · 2025 · Journal of Diabetes and its Complications
  11. All-cause mortality and risk factors in patients with type 1 diabetes in Castilla-La Mancha, Spain. DIACAM1 2010–2020 study
    Pedro José Pinés Corrales, Julia Sastre Marcos, Gema López Gallardo, Jesús Moreno-Fernández, Sandra Herranz Antolín, Iván Quiroga López, Florentino Del Val Zaballos, Javier González López, José Joaquín Alfaro Martínez · 2023 · Primary care diabetes
  12. Metabolic control of type 1 diabetes in youth with autism spectrum disorder: A multicenter Diabetes-Patienten-Verlaufsdokumentation analysis based on 61 749 patients up to 20 years of age
    Jean-François Lemay, Stefanie Lanzinger, Danièle Pacaud, Paul Lukas Plener, A Fürst-Burger, Torben Biester, Dörte Hilgard, Eggert Lilienthal, Angela Galler, Gabriele Berger et al. · 2018 · Pediatric Diabetes
  13. Evaluación y manejo del riesgo cardiovascular residual en el paciente con diabetes
    José Antonio Gimeno Orna, José Jorge Ortez Toro, Carlos Miguel Peteiro Miranda · 2019 · Endocrinología Diabetes y Nutrición
  14. Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes
    Lidia Sojo-Vega, Mònica Recasens, Joan Martínez, Alexandre Aguilera, Maria Ayala, Natàlia Admetlla, Paula Pellicer, Cristina Blay, Berta Fabregat, Mariona Esteve-Serra et al. · 2024 · Cardiovascular Diabetology
  15. Skin Autofluorescence and Clinical Outcomes in Patients with Coronary Artery Disease
    Hiroyoshi Kawamoto, Shinsuke Hanatani, Kenichi Tsujita, Neil Ruparelia, Shengpu Chou, Yasuyuki Kono, Sunao Nakamura · 2023 · Journal of Atherosclerosis and Thrombosis
  16. Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions
    Kathrin Thiem, Geerte Hoeke, Enchen Zhou, Anneke Hijmans, Tom Houben, Margien G. S. Boels, Isabel M. Mol, Esther Lutgens, Ronit Shiri‐Sverdlov, Johan Bussink et al. · 2019 · Diabetes and Vascular Disease Research
  17. Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study
    Christian Stevns Hansen, Marit E. Jørgensen, Marek Malík, Daniel R. Witte, Eric John Brunner, Ádám Gyula Tabák, Mika Kivimaki B, Dorte Vistisen · 2021 · Diabetes Care
  18. Hypoglycemia in children with type 1 diabetes: unawareness is a concrete risk
    Simone Franchini, Laura Comegna, Giovanni Prezioso, Annalisa Blasetti · 2016 · Current Medical Research and Opinion
  19. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study
    Elke R. Fährmann, LAURA J. ADKINS, Henry Keane Driscoll · 2021 · Diabetes Care
  20. Advanced cardiovascular physiology in an individual with type 1 diabetes after 10-year ketogenic diet
    Joseph C. Watso, Austin T. Robinson, Saiful Singar, Jens N. Cuba, Andrew Paul Koutnik · 2024 · American Journal of Physiology-Cell Physiology
  21. Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
    Yuanjie Mao, Jen‐Tzer Gau, Ning Jiang · 2024 · Endocrinology Diabetes & Metabolism
  22. Effect of Sodium-glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Songwei Wang, Yueqi Zhang, Abudunaibi Balati, Bing Li, Lei Dai, Dan Yu · 2025 · The Journal of Clinical Endocrinology & Metabolism
  23. Association of glycemic variability and time in range with lipid profile in type 1 diabetes
    Mariana Isabel Salsa Castelo, Celestino Neves, João Sérgio Neves, Davide Maurício Carvalho · 2023 · Endocrine
  24. Type 1 diabetic patients have better endothelial function after simultaneous pancreas–kidney transplantation than after kidney transplantation with continued insulin therapy
    Jacek Ziaja, A. Kowalik, Aureliusz Kolonko, Dorota Kamińska, Aleksander Jerzy Owczarek, Agata Kujawa-Szewieczek, Mariusz Andrzej Kusztal, Joanna Badura, Dominika Bożek-Pająk, Piotr Stanisław Choręza et al. · 2017 · Diabetes and Vascular Disease Research
  25. Serum urate and cardiovascular events in the DCCT/EDIC study
    Alicia Josephine Jenkins, Barbara H. Braffett, Arpita Basu, Ionut Bebu, Samuel E. Dagogo-Jack, Trevor John Orchard, Amisha Wallia, Maria Fernanda Lopes-Virella, William Timothy Garvey, John M. Lachin et al. · 2021 · Scientific Reports
  26. Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naïve adults with type 1 diabetes
    Yuhan A. Goh, Nick S.R. Lan, Kathryn Linn, Chris Wood, Ashu Gupta, Bu Beng Yeap, P. Gerry Fegan · 2023 · Journal of Diabetes and its Complications
  27. Hemoglobin A1c and retinal arteriolar narrowing in children with type 1 diabetes: the diagnostics of early atherosclerosis risk in kids study
    Michael Wurm, Leonie Kuehnemund, Lisa Maier, Mi Xia, Kai Lichte, Kristiane Hallermann, Alexandra Krause, Andreas Krebs, Henner Hanssen, Peter Deibert et al. · 2019 · Pediatric Diabetes
  28. The phenomenon of HbA1c stability and the risk of hypoglycemia in long-standing type 1 diabetes
    Bogumił Wolnik, Elżbieta Orłowska-Kunikowska, Magdalena Błaszkowska, Beata Graff, Jacek Wolf, Leszek Czupryniak, Krzysztof Narkiewicz · 2019 · Diabetes Research and Clinical Practice
  29. Genetic association with autoimmune diseases identifies molecular mechanisms of coronary artery disease
    Sophia Kerns, Katherine A. Owen, Andrea R. Daamen, Jessica Kain, Amrie C. Grammer, Peter E. Lipsky · 2024 · iScience
  30. Relationship between peripheral neuropathy, diastolic function and adverse cardiovascular outcome in individuals with type 1 diabetes mellitus without known cardiovascular disease: Results from the Thousand & 1 Study
    Gorm Mørk Hansen, Peter Godsk Jørgensen, Henrik Ullits Andersen, Peter R Rossing, Magnus Thorsten Jensen · 2020 · Diabetes Obesity and Metabolism
  31. Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes
    Ilze Salna, Edgars Salna, Leonora Pahirko, Sabīne Skrebinska, Regīna Krikova, Inese Folkmane, Valdis Pīrāgs, Jeļizaveta Sokolovska · 2021 · Journal of Diabetes and its Complications
  32. Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control
    Rachel G. Miller, Tina Costacou · 2022 · Current Cardiology Reports
  33. Metabolic predictors of pain, fatigue, depression and quality of life in people with long‐term type 1 diabetes—the Dialong study
    Anne Karin Molvær, Marjolein M. Iversen, Jannicke Igland, Mark F. Peyrot, Grethe Seppola Tell, Kristine Bech Holte, Vincent M. Monnier, Ingebjørg Seljeflot, Tore Julsrud Berg · 2022 · Diabetic Medicine
  34. Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis
    Tonet Serés‐Noriega, Emilio Ortega, Verónica Perea, Marga Giménez, Laura Boswell, Karla Mariaca, Carla Font, Alex Mesa, Clara Viñals, Jesús Blanco et al. · 2023 · Diabetes Therapy
  35. Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes
    Braffett, Barbara H., El ghormli, Laure, Martin, Catherine, White, Neil H., Hirsch, Irl B., Bantle, Anne, Carlson, Anders, Leschek, Ellen, Gubitosi-Klug, Rose, Soliman, Elsayed Z. et al. · 2025 · Cardiovascular Diabetology
  36. Investigating the presence and detectability of structural peripheral arterial changes in children with well-regulated type 1 diabetes versus healthy controls using ultra-high frequency ultrasound: a single-centre cross-sectional and case-control study
    Ebba Bergdahl, Gun Forsander, Frida Sundberg, Linda Milkovic, Frida Dangardt · 2025 · EClinicalMedicine
  37. Too Much Dietary Flexibility May Hinder, Not Help: Could More Specific Targets for Daily Food Intake Distribution Promote Glycemic Management among Youth with Type 1 Diabetes?
    Angelica Cristello Sarteau, Elizabeth J. Mayer‐Davis · 2022 · Nutrients
  38. Cumulative exposures to glycaemia and lipids are associated with coronary artery disease in type 1 diabetes: a call for action
    Rebecka Bergdal, Valma Harjutsalo, Per‐Henrik Groop, Stefan Mutter, on behalf of the FinnDiane Study Group · 2025 · Cardiovascular Diabetology
  39. Relationship of the Aggregation of Cardiovascular Risk Factors in the Parasympathetic Modulation of Young People with Type 1 Diabetes
    Anne Kastelianne França da Silva, Diego Giulliano Destro Christófaro, Laís Manata Vanzella, Franciele Marques Vanderlei, Maria Júlia Lopez Laurino, Luiz Carlos Marques Vanderlei · 2019 · Medicina
  40. The partial clinical remission phase of type 1 diabetes: early-onset dyslipidemia, long-term complications, and disease-modifying therapies
    Benjamin Udoka Nwosu · 2025 · Frontiers in Endocrinology
  41. miR-449a disturbs atherosclerotic plaque stability in streptozotocin and high-fat diet-induced diabetic mice by targeting CEACAM1
    Jie Yu, Han Liu, Yu Chen, Ling Wang, Peng Chen, Yue Zhao, Chunxia Ou, Wei Chen, Jie Hu, Yu Wang et al. · 2024 · Diabetology & Metabolic Syndrome
  42. [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines.]
    Pedro Armario, Carlos Brotons, Roberto Elosúa, Maria Alonso de Leciñana, Almudena Castro, Albert Benet i Clarà, Olga Cortés, Ángel Díaz Rodríguez, María Herranz, Soledad Justo et al. · 2020 · PubMed Central
  43. Asociación entre síntomas depresivos de las madres y control metabólico en adolescentes con Diabetes Mellitus tipo 1
    Denise Von Borries, Patricio Astudillo P., Viviana Perez, Hernán García F, Karime Rumié, Hernán García B · 2020 · Revista chilena de pediatría
  44. Genetic Risk Score Enhances Coronary Artery Disease Risk Prediction in Individuals With Type 1 Diabetes
    Raija Lithovius, Anni A. Antikainen, Stefan Mutter, Erkka Valo, Carol M. Forsblom, Valma Harjutsalo, Niina Sandholm, Per‐Henrik Groop · 2022 · Diabetes Care
  45. Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes
    Marcel Maziyar Nejatian, Nick S.R. Lan, Bu Beng Yeap, Girish Dwivedi, P. Gerry Fegan, Abdul Rahman Ihdayhid · 2022 · Diabetes Research and Clinical Practice
  46. Type 1 Diabetes and Cardiovascular Health
    Maria Pesantez, Osagie A. Ebekozien, Francesco Vendrame · 2023 · Endocrinology and Metabolism Clinics of North America
  47. Mediation analysis for estimating cardioprotection of longitudinal RAS inhibition beyond lowering blood pressure and albuminuria in type 1 diabetes
    Jingchuan Serena Guo, Ashley Isaac Naimi, Maria M. Brooks, Matthew F. Muldoon, Trevor John Orchard, Tina Costacou · 2019 · Annals of Epidemiology
  48. Markedly increased incidence of critical illness in adults with Type 1 diabetes
    Ruth Ann Marrie, Elizabeth A. C. Sellers, H. Chen, Randy Fransoo, Charles Noah Bernstein, Carol Ann Hitchon, CHRISTINE A. PESCHKEN, Allan Garland · 2017 · Diabetic Medicine
  49. Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
    Chun‐Hsien Lin, Chia‐Hsuin Chang, Lee‐Ming Chuang · 2020 · Journal of Diabetes Investigation
  50. Impact of anemia on HbAC level in type 2 diabetes mellitus patients
    Gouri Avadhut Gulavani, Sanjyoti Ankur Panchbudhe, Shubhangi Haribhau Gawade, Farheen B. Mujawar · 2023 · International Journal of Clinical Biochemistry and Research
  51. Prevalence and predictors of female sexual dysfunction among sexually active women in the diabetes prevention program outcomes study
    Priyanka Gupta, Lindsay Doherty, Marinella G. Temprosa, Rodica Pop‐Busui, Kishore M. Gadde, Prachi Singh, Arthur Hamie Owora, Hunter Wessells, Aruna V. Sarma · 2024 · Neurourology and Urodynamics
  52. Muscle insulin resistance in type 1 diabetes with coronary artery disease
    Katherine V. Williams, Christina M. Shay, Julie C. Price, Bret H. Goodpaster, Carol A. Kelley, David E. Kelley, Trevor John Orchard · 2020 · Diabetologia
  53. Creatine kinase is associated with glycated haemoglobin in a nondiabetic population. The Tromsø study
    Svein Ivar Bekkelund · 2023 · PLoS ONE
  54. Comprehensive Factors for Predicting the Complications of Diabetes Mellitus: A Systematic Review
    Madurapperumage Erandathi, William Yu Chung Wang, Michael Mayo, Ching‐Chi Lee · 2024 · Current Diabetes Reviews
  55. Nutrition Therapy for Diabetes and Lipid Disorders
    J. Zimmerman, Wahida Karmally · 2017 · American Diabetes Association eBooks
  56. Interpreting Type 1 Diabetes Management via Contrastive Explanations
    Daniele Melloni, Andrea Zingoni · 2024 · IEEE International Conference on Metrology for eXtended Reality, Artificial Intelligence and Neural Engineering (MetroXRAINE)
  57. Annexin V+ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
    Vibeke Bratseth, Hanna Dis Margeirsdottir, Gemma Chiva‐Blanch, Martin Heier, Svein Solheim, Harald Arnesen, Knut Dahl‐Jørgensen, Ingebjørg Seljeflot · 2020 · Journal of Diabetes Research
  58. Coronary artery calcification in type 1 diabetes after 10-year ketogenic diet
    Andrew Paul Koutnik, Belinda S Lennerz, Larry C. Deeb, Joseph C. Watso · 2025 · Journal of Applied Physiology
  59. L’autofluorescence des produits de glycation avancée (AGEs) et son utilisation comme marqueur de mémoire métabolique et prédicteur de complications
    Fritz‐Line Vélayoudom‐Céphise, Kalina Rajaobelina, Christelle Blanc-Bisson, Marine Rigo, Ninon Foussard, Laurence Blanco, Kamel Mohammedi, Magalie Haissaguerre, Catherine Helmer, Vincent Rigalleau · 2019 · Médecine des Maladies Métaboliques
  60. Comentario del CEIPV a la actualización de las Guías Europeas de Prevención Vascular en la Práctica Clínica
    Pedro Armario, Carlos Brotons, Roberto Elosúa, María Alonso de Leciñana, Almudena Castro, Albert Benet i Clarà, Olga Cortés, Ángel Díaz Rodríguez, María Herranz, Soledad Justo et al. · 2021 · Clínica e Investigación en Arteriosclerosis
  61. Early increase in carotid intima-media thickness in women with childhood-onset type 1 diabetes compared with healthy peers: the Norwegian Atherosclerosis and Childhood Diabetes study
    Aida Simeunovic, Cathrine Brunborg, Martin Heier, Tore Julsrud Berg, Knut Dahl‐Jørgensen, Hanna Dis Margeirsdottir · 2025 · BMJ Open Diabetes Research & Care
  62. Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes: A post hoc analysis of the DCCT / EDIC study
    Marga A. G. Helmink, Steven H J Hageman, Frank L.J. Visseren, Wendela L. de Ranitz‐Greven, Harold W. de Valk, Thomas T. van Sloten, Jan Westerink · 2023 · Diabetic Medicine
  63. Comment on Gordin et al. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 2018;41:815–822
    Marie Azar, Élise Coirier, Marie‐Noëlle Delyfer, Jean‐François Korobelnik, Kamel Mohammedi, Laurence Blanco, Laure Alexandre, Marie Monlun, Vincent Rigalleau · 2018 · Diabetes Care
  64. Asymmetric Dimethylarginine as a Potential Biomarker for Cardiovascular Risk Assessment in Long-Standing Type 1 Diabetes Mellitus
    Gergana M Chausheva, Sevim Shefket, Yana Bocheva, Κaloyan Tsochev, Tatiana Chalakova, Yoto Trifonov Yotov, Violeta Iotova · 2026 · Galician Medical Journal
  65. Cardiovascular risk equations in type 1 diabetes: from generic models to personalized prediction
    Tonet Serés‐Noriega, Irene Aguiló Lafarga, Verónica Perea, Clara Viñals, Antonio Jesús Amor · 2026 · Annals of Medicine
  66. The role of bempedoic acid in the management of dyslipidaemia in people with diabetes: an expert opinion of Italian diabetologists
    Massimo Federici, Raffaella Buzzetti, Riccardo Candido, Salvatore De Cosmo, Angela Pirillo, Giuseppina Russo, Giorgio Sesti, Angelo Avogaro · 2026 · Cardiovascular Diabetology
  67. Atherosclerosis in patients with type 1 diabetes
    David Karásek · 2019 · Vnitřní lékařství
  68. Research Article Diagnostic value of serum C-reactive protein as biomarker of cardiovascular risk in patients with type 2 diabetes
    Truong Dinh Cam, Trung-Dung Hoang, Hoangvy Le, Ha Van Quyet, P.T. Trung, N.T. Binh, Vu Thi Minh Thuc · 2021 · Genetics and Molecular Research
  69. A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes
    Ágnes Benedict, Emily R. Hankosky, Kinga Marczell, Jieling Chen, David J. Klein, J. Jaime, Jay Patrick Bae, Brian D. Benneyworth · 2022 · PharmacoEconomics
  70. Association between metabolic phenotype and diabetic kidney disease in adult-onset type 1 diabetes patients from China: A multi-center cross-sectional study
    Jun Jiang, Peng Wang, Jielong Jiang, Tengwen Zhang, Yu Ding, Xueying Zheng, Sihui Luo, Jinhua Yan, Kuanxiao Tang, Daizhi Yang · 2025 · Diabetes Research and Clinical Practice
  71. Risque cardiovasculaire du patient diabétique de type 1
    Bruno L Vergès · 2021 · Médecine des Maladies Métaboliques
  72. Diabetes and the cardiovascular system
    David Levy MD FRCP · 2017
  73. Reversal of secondary complications of type 1 diabetes (nephropathy, neuropathy, retinopathy, and cardiopathy)
    Caterina Conte, Antonio Secchi · 2019 · Elsevier eBooks
  74. Fuelling the fire : Immunometabolism of monocytes and macrophages in obesity & diabetes
    Xanthe A.M.H. van Dierendonck · 2021
  75. Significance of determination of hemodynamic phenotypes in early diagnosis of cardiovascular disorders in children with diabetes mellitus
    G.O. Lezhenko, O.Ye. Pashkovа, Катерина Валеріївна Самойлик · 2021 · Pathologia
  76. Kardiovaskuläre Risiken in der 4.–6. Lebensdekade mit Diabetes mellitus Typ 1
    Young Hee Lee-Barkey, Bernd Stratmann, Diethelm Tschöpe · 2022 · Der Diabetologe
  77. Journal watch
    2021 · Trends in Urology & Men s Health
  78. Response to Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2021;44;2132–2139
    Elke R. Fährmann, Henry Keane Driscoll · 2022 · Diabetes Care
  79. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study
    Elke R. Fährmann, LAURA J. ADKINS, Henry Keane Driscoll · 2021
  80. Evaluación y manejo del riesgo cardiovascular residual en el paciente con diabetes
    José Antonio Gimeno Orna, José Jorge Ortez Toro, Carlos Miguel Peteiro Miranda · 2020 · Endocrinología Diabetes y Nutrición (English ed )
  81. Bernard Zinman: A Canadian Clinician Scientist Changing the Management of Diabetes
    Daniel J. Drucker · 2022 · Diabetes Care
  82. Commentary to "Perioperative care in open aortic vascular surgery: A consensus statement by the Enhanced Recovery After Surgery (ERAS) Society and Society for Vascular Surgery"
    Álvaro Torres Blanco · 2023 · Angiología
  83. Commentary to "How to Treat Peripheral Arteriovenous Malformations"
    Eliseo Candela · 2023 · Angiología
  84. The relationship between abnormal myocardial alterations and glycemic control validated by cardiac magnetic resonance in a pig model of diabetes mellitus
    Lu Zhang, Yingkun Guo, Zhi‐gang Yang, Jiang Li, Wei‐Feng Yan, Huayan Xu · 2023 · Research Square
  85. Treatment goal achievement and association with 10-year and 30-year atherosclerotic cardiovascular disease risks in patients with type 1 diabetes mellitus in Taiwan: The Taiwan Diabetes Registry
    Hsuan-Wei Lin, Yun‐Kai Yeh, Tsung-Hui Wu, Wayne Huey‐Herng Sheu, Su-Huey Lo, Yen‐Po Yeh, Chien‐Ning Huang, Chang‐Hsun Hsieh, Chii‐Min Hwu · 2023 · Research Square
  86. Secondary Complications: Pancreas Versus Islet Transplantation
    Paola Maffi, Davide Catarinella, Antonio Secchi · 2023 · Springer eBooks
  87. Novel Approach for AI-Based Risk Calculator Development Using Transfer Learning Suitable for Embedded Systems
    Antonio J. Rodríguez-Almeida, Himar A. Fabelo, Cristina Soguero-Ruíz, Rosa M. Sánchez-Hernández, Ana María Wägner, Gustavo M. Callicó · 2023 · Euromicro Conference on Digital System Design (DSD)
  88. Stars and Rising Stars in Pediatric Endocrinology: 2022
    2024 · Frontiers research topics
  89. Impact of glycated hemoglobin on iron deficiency anemia in type 2 diabetes mellitus
    Nita Sahi, Richa Bharatkumar Modi, Nikita A Pandya, Disha Sahi · 2024 · International Journal of Advanced Biochemistry Research
  90. Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: systematic review and meta-analysis
    Rui Sun, Jianxin Wang, Meng Li, Jingen Li, Yi Pan, Birong Liu, Gregory Y.H. Lip, Lijing Zhang · 2024
  91. Heterogeneous response of estimated insulin sensitivity indices to metformin in young individuals with type 1 diabetes and different phenotypes
    Luana Aparecida Ramaldes, Sarah Simaan dos Santos, Patricia Medici Dualib, João Roberto de Sá, Sérgio Atala Dib · 2024 · Diabetology & Metabolic Syndrome
  92. Metabolic Associations between Cardiovascular Disease, Diabetes and Kidney Disease
    佳欣 王 · 2025 · Advances in Clinical Medicine
  93. Behavior Change Counseling Strategies (BCC) as an Effective Treatment Approach Along with Insulin Regimens for Type1 Young Adult Diabetes Mellitus Patients from a Busy Diabetic Clinic—A Randomized Single-Blinded Controlled Trial: Pilot Study
    Shiju Raman Unni, Saud Al Harthy, Jeffry Singh, Mary McCallum · 2025 · Journal of Diabetes and Endocrine Practice
  94. A New Simulation Model to Estimate the Long-term Health and Cost Outcomes of Interventions for People With Type 1 Diabetes
    Carolina Barbosa, Thomas J. Hoerger, Nicole A. Mack, Georgiy Bobashev, Simon J. Neuwahl, Rainer Hilscher, Trevor John Orchard, Tina Costacou, Rachel G. Miller, Ralph D’Agostino et al. · 2025
  95. Lipid metabolism in type 1 diabetes initiation and progression to vascular disease
    Nicholas S Borowsky, Rodney Michel, Khemraj Hirani, Francesco Vendrame · 2025 · Elsevier eBooks
  96. Statins and Type 1 Diabetes: Impact on Cardiovascular Outcomes and surrogates. Systematic Review and meta-analysis
    Karen Fériz, Pablo Corral, María Bernarda Iriarte-Durán, Claudia Milena Gómez Giraldo, Natalia Nardelli, Oriana Arias‐Valderrama, María Camila Gómez-Ayala · 2025 · Current Diabetes Reports
  97. Glycemic Control and Lipid Profile in Adolescents with Type 1 Diabetes: The Moderator Role of Cardiorespiratory Fitness
    Gabriel Ribeiro Cordeiro, Valderi Abreu de Lima, Caroline Brand, Juliano Boufleur Farinha, André de Camargo Smolarek, Emerson Carraro, Neiva Leite, Luís Paulo Gomes Mascarenhas · 2025 · Brazilian Archives of Biology and Technology
  98. Red cell distribution width positively correlates with 10-year risk of cardiovascular disease among people with type 1 diabetes as assessed by the Steno Type 1 Risk Engine
    Dariusz Naskręt, Stanisław Piłaciński, Paweł Niedźwiecki, Michał Kulecki, Dorota Zozulińska‐Ziółkiewicz · 2025 · Acta Diabetologica
  99. Frequency and characteristics of complications and concomitant diseases in children with type 1 diabetes mellitus who fell ill in preschool age
    Д. Н. Лаптев, Irina Alexandrovna Eremina, N. A. Goncharova, А. А. Федоринин · 2025 · Diabetes Mellitus
  100. Additional file 1 of Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population
    Petria, Iulia, SAMUEL ALBUQUERQUE, Gael P. Varoquaux, Jill-Jênn Vie, Nicolas Venteclef, Kamel Mohammedi, Ronan Roussel, Marion Camoin, Gianluca Perseghin, Gilberto Velho et al. · 2022 · Figshare